Robins Chad M: insider trades.
Robins Chad M reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($14.9M), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- ROBINS CHAD M
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Director, Officer · CEO and Chairman | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-18 | Adaptive Biotechnologies Corp | M | 278,676 | $6.55 | 2,459,194 | Form 4 |
| 2026-08-18 | Adaptive Biotechnologies Corp | S | 204 | $25.14 | 2,180,518 | Form 4 |
| 2026-08-18 | Adaptive Biotechnologies Corp | S | 278,472 | $24.48 | 2,180,722 | Form 4 |
| 2026-08-17 | Adaptive Biotechnologies Corp | S | 2,525 | $25.57 | 2,180,518 | Form 4 |
| 2026-08-17 | Adaptive Biotechnologies Corp | M | 321,324 | $6.55 | 2,501,842 | Form 4 |
| 2026-08-17 | Adaptive Biotechnologies Corp | S | 318,799 | $25.08 | 2,183,043 | Form 4 |
Questions
What stock did Robins Chad M buy or sell?
Robins Chad M reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($14.9M), across 1 company.
Is Robins Chad M the same person as other filers with this name?
This page covers SEC CIK 1780649 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/robins-chad-m-1780649.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.